Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

301.31
Delayed Data
As of Oct 22
 +3.32 / +1.11%
Today’s Change
271.37
Today|||52-Week Range
442.00
-19.33%
Year-to-Date
Here's Why Dermira Stock Is Rocketing Higher Today
Oct 18 / MotleyFool.com - Paid Partner Content
Are These 3 Beaten-Down Biotech Stocks Bargains Now?
Oct 17 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close297.99
Today’s open305.00
Day’s range301.20 - 306.93
Volume729,069
Average volume (3 months)755,407
Market cap$32.3B
Data as of 4:00pm ET, 10/22/2019

Growth & Valuation

Earnings growth (last year)+100.98%
Earnings growth (this year)+2.17%
Earnings growth (next 5 years)+8.00%
Revenue growth (last year)+14.28%
P/E ratio16.7
Price/Sales6.39
Price/Book3.73

Competitors

 Today’s
change
Today’s
% change
ALXNAlexion Pharmaceutic...-1.45-1.44%
VRTXVertex Pharmaceutica...+7.53+4.10%
SGENSeattle Genetics Inc-2.25-2.23%
INCYIncyte Corp-0.08-0.10%
Data as of 4:00pm ET, 10/22/2019

Financials

Next reporting dateNovember 5, 2019
EPS forecast (this quarter)$6.35
Annual revenue (last year)$6.7B
Annual profit (last year)$2.4B
Net profit margin36.42%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Tarrytown, New York

Forecasts